Cupid Limited Receives CE (EU IVDR) Certification for HIV 1&2 and Hepatitis B IVD Test Kits, Expanding Global Market Access in Diagnostics January 30, 2026 Cupid Limited, (BSE – 530843, NSE – CUPID), a diversified Indian healthcare and consumer products company with a growing focus on in-vitro diagnostics (IVD),wellness, and… Continue Reading
Cupid Limited Delivers Record Q3 FY26 Performance with 201 percent YoY Growth in EBITDA January 30, 2026 Mumbai (Maharashtra) [India], January 30: Cupid Limited (Cupid, The Company), announced that it delivered the strongest quarter in its history during Q3 FY26 (quarter ended 31 December… Continue Reading
